|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
04/19/2024 |
$28.67 |
$29.53 |
$28.67 |
$29.40 |
361.60K | 04/22/2024 |
$29.56 |
$30.30 |
$29.28 |
$29.71 |
352.50K | 04/23/2024 |
$29.75 |
$31.84 |
$29.59 |
$29.95 |
201.20K | 04/24/2024 |
$29.96 |
$30.40 |
$29.82 |
$30.26 |
201.70K | 04/25/2024 |
$30.03 |
$30.22 |
$29.17 |
$29.31 |
351.50K |
|
Supernus Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases. Co.'s products include Trokendi XR and Oxtellar XR, which are the once-daily extended release topiramate and oxcarbazepine products indicated for the treatment of epilepsy; APOKYN, which is a product indicated for the intermittent treatment of hypomobility or off episodes in patients with Parkinson's Disease (PD); XADAGO, which is an once-daily product indicated as adjunctive treatment to levodopa/carbidopa in patients with PD; and MYOBLOC, which is a product indicated for the treatment of cervical dystonia and sialorrhea in adults. | |
|
Supernus Pharmaceuticals (SUPN) has the following price history information. Looking back at SUPN historical stock prices for the last five trading days, on April 19, 2024, SUPN opened at $28.67, traded as high as $29.53 and as low as $28.67, and closed at $29.40. Trading volume was a total of 361.60K shares. On April 22, 2024, SUPN opened at $29.56, traded as high as $30.30 and as low as $29.28, and closed at $29.71. Trading volume was a total of 352.50K shares. On April 23, 2024, SUPN opened at $29.75, traded as high as $31.84 and as low as $29.59, and closed at $29.95. Trading volume was a total of 201.20K shares. On April 24, 2024, SUPN opened at $29.96, traded as high as $30.40 and as low as $29.82, and closed at $30.26. Trading volume was a total of 201.70K shares. On April 25, 2024, SUPN opened at $30.03, traded as high as $30.22 and as low as $29.17, and closed at $29.31. Trading volume was a total of 351.50K shares.
SUPN Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Supernus Pharmaceuticals shares, starting with a $10,000 purchase of SUPN, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/29/2014 |
|
End date: |
04/25/2024 |
|
Start price/share: |
$7.57 |
|
End price/share: |
$29.31 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
287.19% |
|
Average Annual Total Return: |
14.50% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$38,716.29 |
|
Years: |
10.00 |
|
|
|
Date |
Close |
04/19/2024 | $29.40 | 04/22/2024 | $29.71 | 04/23/2024 | $29.95 | 04/24/2024 | $30.26 | 04/25/2024 | $29.31 |
|
|